Drug intelligence / Profile preview

fluvalinate

Development stage
Unknown
Lead developer
Nihon Nohyaku
Modality
Small Molecules
Administration
Topical
01

Overview

Fluvalinate is a synthetic pyrethroid acaricide used in animal health for the control of parasitic mite infestations in honey bee colonies, most notably the *Varroa destructor* (Varroa mite). Originally developed for agricultural use, the tau-isomer (tau-fluvalinate) was specifically registered for apiculture due to its high efficacy against mites and relatively low toxicity to honey bees at therapeutic doses. Nihon Nohyaku registered the product in Japan in 1992. The drug acts as a neurotoxin by targeting voltage-gated sodium channels in the nerve membranes of the mites. It binds to these channels and prevents them from closing, which leads to a prolonged influx of sodium ions, resulting in repetitive nerve firing, paralysis, and eventual death of the parasite. In a hive setting, it is typically administered via impregnated polymer strips that provide a sustained release of the active ingredient as bees crawl over them and distribute the chemical throughout the colony via social contact.

Brand names
Apistan
Other names
tau-fluvalinateMavrikKlartan
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on fluvalinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluvalinate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call